Evotec SE (ETR:EVT – Get Free Report) shares traded down 0.5% during trading on Wednesday . The stock traded as low as €8.72 ($9.18) and last traded at €8.81 ($9.27). 1,555,984 shares were traded during mid-day trading, an increase of 14% from the average session volume of 1,360,000 shares. The stock had previously closed at €8.85 ($9.32).
Evotec Price Performance
The firm has a market capitalization of $1.54 billion, a PE ratio of -9.06, a price-to-earnings-growth ratio of 0.98 and a beta of 1.05. The business’s 50 day moving average is €7.68 and its two-hundred day moving average is €7.64. The company has a debt-to-equity ratio of 46.81, a quick ratio of 2.97 and a current ratio of 1.83.
About Evotec
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health.
Featured Articles
- Five stocks we like better than Evotec
- What is Insider Trading? What You Can Learn from Insider Trading
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- Investing In Preferred Stock vs. Common Stock
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- 3 Warren Buffett Stocks to Buy Now
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
